Health In Tech, Inc. Files IPO Amendment

TL;DR

Health In Tech IPO filing updated. Get ready.

AI Summary

Health In Tech, Inc. filed an S-1/A amendment on September 24, 2024, for its initial public offering under registration number 333-281853. The company, based in Stuart, Florida, is seeking to register an unspecified number of securities. The filing indicates the company's principal executive offices are located at 701 S. Colorado Ave, Suite 1, Stuart, FL 34994, with a contact phone number of 888-373-0333.

Why It Matters

This S-1/A filing is a step in Health In Tech, Inc.'s process to become a publicly traded company, which could impact its ability to raise capital and its future business operations.

Risk Assessment

Risk Level: medium — As an S-1/A filing, it represents a company in the early stages of going public, which inherently carries significant risks related to market reception and operational execution.

Key Numbers

• 333-281853 — SEC Registration Number (Identifies the specific registration for this offering.)

Key Players & Entities

• Health In Tech, Inc. (company) — Registrant
• 333-281853 (registration_number) — SEC Registration Number
• September 24, 2024 (date) — Filing Date
• 701 S. Colorado Ave, Suite 1 Stuart, FL 34994 (address) — Principal Executive Offices
• 888-373-0333 (phone_number) — Business Phone Number
• Tim Johnson (person) — Chief Executive Officer

FAQ

Key Financial Figures

• $0.001 — shares of Class A Common Stock, $0.001 par value per share (“Class&#x00
• $4.00 — price anticipated to be in the range of $4.00 to $5.00 per share, through the underwr
• $5.00 — icipated to be in the range of $4.00 to $5.00 per share, through the underwriter name
• $4.5 — ission To change the non -transparent $4.5 trillion 1 healthcare industry w

Filing Documents

• ea0200040-09.htm (S-1/A) — 9071KB
• ea020004009ex1-1_health.htm (EX-1.1) — 246KB
• ea020004009ex3-2_health.htm (EX-3.2) — 218KB
• ea020004009ex5-1_health.htm (EX-5.1) — 15KB
• ea020004009ex10-10_health.htm (EX-10.10) — 117KB
• ea020004009ex10-11_health.htm (EX-10.11) — 26KB
• ea020004009ex23-2_health.htm (EX-23.2) — 4KB
• ea020004009ex99-4_health.htm (EX-99.4) — 2KB
• thealth_logo.jpg (GRAPHIC) — 148KB
• tamerican_logo.jpg (GRAPHIC) — 71KB
• thealth_logo1.jpg (GRAPHIC) — 147KB
• timage_01.jpg (GRAPHIC) — 351KB
• timage_02.jpg (GRAPHIC) — 489KB
• timage_04.jpg (GRAPHIC) — 661KB
• timage_05.jpg (GRAPHIC) — 483KB
• timage_06.jpg (GRAPHIC) — 642KB
• timage_07.jpg (GRAPHIC) — 572KB
• timage_08.jpg (GRAPHIC) — 809KB
• timage_09.jpg (GRAPHIC) — 818KB
• ex5-1_001.jpg (GRAPHIC) — 12KB
• ex5-1_002.jpg (GRAPHIC) — 15KB
• 0001213900-24-081492.txt ( ) — 16888KB

RISK FACTORS

RISK FACTORS   15 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS   36

USE OF PROCEEDS

USE OF PROCEEDS   37 DIVIDEND POLICY   38 CAPITALIZATION   39

DILUTION

DILUTION   41 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   43

BUSINESS

BUSINESS   67 MANAGEMENT   79 EXECUTIVE AND DIRECTOR COMPENSATION   85 PRINCIPAL STOCKHOLDERS   92 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS   94

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK   95 SHARES ELIGIBLE FOR FUTURE SALE   100

UNDERWRITING

UNDERWRITING   102 EXPERTS   113 LEGAL MATTERS   113 WHERE YOU CAN FIND MORE INFORMATION   113 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS   F-1 You should rely only on the information contained in this prospectus. We have not authorized any other person to provide you with information different from or in addition to that contained in this prospectus, and we take no responsibility for any other information others may give you. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. No action is being taken in any jurisdiction outside the United States to permit a public offering of our Class A Common Stock or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus applicable to that jurisdiction. As used in this prospectus, unless the context indicates or otherwise requires, “the Company,” “our Company,” “we,” “us,” and “our” refer to Health In Tech, Inc., a Nevada corporation, and its consolidated subsidiaries. i Table of Contents CERTAIN TERMS AND DEFINITIONS •          “Broker” or “insurance broker” is an intermediary who sells, solicits or negotiates insurance policies on behalf of a client for

View Full Filing

View this S-1/A filing on SEC EDGAR